Yepes-Calderón, Manuela http://orcid.org/0000-0002-4693-5974
van der Veen, Yvonne
Martín del Campo S, Fernando
Kremer, Daan
Sotomayor, Camilo G.
Knobbe, Tim J.
Vos, Michel J.
Corpeleijn, Eva
de Borst, Martin H.
Bakker, Stephan J. L.
,
Funding for this research was provided by:
Astellas Pharma, Netherlands (TransplantLines Biobank, Cohort study)
Topconsortium voor Kennis en Innovatie (PPP-2019-032, PPP-2022-015)
Chiesi Farmaceutici (PA-SP/PRJ-2020-9136)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (14939)
Article History
Received: 30 October 2023
Accepted: 2 May 2024
First Online: 29 May 2024
Declarations
:
: The authors have no competing interests to declare relevant to this article's content.
: This study protocol was reviewed and approved by the University Medical Center review board, approval number (METc 2014/077). Written informed consent was obtained from participants to be enrolled to the study.